Misplaced Pages

EudraLex

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
EU laws on medicinal products
This article is part of a series on
Politics of the European Union
Member states (27)
Candidate countries
Countries with suspended accession negotiations
Applicant countries

Treaties and Declarations
Opt-outs
Treaties of accession 1972, 1979, 1985, 1994, 2003, 2005, 2011
Treaties of succession 1984, 2020
Other treaties
Abandoned treaties and agreements
Executive institutionsEuropean Council
European Commission
Legislative institutions
Council of the EU
Presidency Poland Poland (January–June 2025)
Configurations

European Parliament
(Members)
National parliaments
Judicial institutionsCourt of Justice of the EU
Auditory institutionsEuropean Court of Auditors
Other auditory bodies
European Central Bank
Other bodiesEuropean Investment Bank Group
European Stability Mechanism
European University Institute
Unified Patent Court
Agencies, decentralised independent bodies and joint undertakings
Other independent bodies
Advisory bodies
Inter-institutional bodies
EuratomEuratom members
Associated states
Euratom since 1 January 2021
Euratom since 1 January 2021
Economic and Monetary UnionEurozone members



Eurogroup



Other currencies in use

Non Euro countries relationship to Euro
Eurozone since 2015
Eurozone since 2015
Schengen Area
Non-EU members

Non-Schengen area EU member states
Schengen Area from January 2023
Schengen Area from January 2023
European Economic AreaEEA members
Non-EU members
Topics
European Economic Area
European Economic Area
Elections
European elections
Elections in EU member states
Law
Policies and issues
Foreign relationsHigh Representative

Foreign relations of EU member states


Defunct bodies
flag European Union portal

EudraLex is the collection of rules and regulations governing medicinal products in the European Union.

Volumes

EudraLex consists of 10 volumes:

  • Concerning Medicinal Products for Human use:
    • Volume 1 - Pharmaceutical Legislation.
    • Volume 2 - Notice to Applicants.
      • Volume 2A deals with procedures for marketing authorisation.
      • Volume 2B deals with the presentation and content of the application dossier.
      • Volume 2C deals with Guidelines.
    • Volume 3 - Guidelines.
  • Concerning Medicinal Products for human use in clinical trials (investigational medicinal products).
    • Volume 10 - Clinical trials.
  • Concerning Veterinary Medicinal Products:
    • Volume 5 - Pharmaceutical Legislation.
    • Volume 6 - Notice to Applicants.
    • Volume 7 - Guidelines.
    • Volume 8 - Maximum residue limits.
  • Concerning Medicinal Products for Human and Veterinary use:
  • Miscellaneous:
    • Guidelines on Good Distribution Practice of Medicinal Products for Human Use (94/C 63/03)

Directives

See also

References

  • Eudralex,The Rules Governing Medicinal Products in the European Union, European Communities Commission. Directorate-General for Industry, Pharmaceuticals and Cosmetics.
  • Markus Hartmann and Florence Hartmann-Vareilles, The Clinical Trials Directive: How Is It Affecting Europe's Noncommercial Research?, PLoS Clin Trials. 2006 June; 1(2): e13

External links

Regulation of therapeutic goods
Americas
Eurasia
Oceania
Categories: